All non-proprietary information must be fully disclosed and publicly available
to include but limited to: efficacy, side effects, test results from all phases of clinical trials, adverse events, financial interests, subsidies, and kickbacks for all drugs (including vaccinations) submitted for approval and release in the US. This would also include the raw data used or collected from all sources regardless of country. NO exceptions, no expense to obtain the information, and no requirement to submit a Freedom of Information Act request.